Dr Emily Stockings is an NHMRC Fellow and Program Lead of ‘Smoking, Vaping and Mental Health’ at The Matilda Centre, the University of Sydney. She has worked with state and federal government agencies to develop clinical guidelines for the prescription of unapproved therapeutic products, including medicinal cannabis. She is expert consultant to the Therapeutic Goods Administration, the Commonwealth Department of Health and the World Health Organization on tobacco control and emerging therapeutic substances.
Mixed messages: policy considerations for the growing use of illicit substances as therapeutic agents in Australia
Policymakers should draw on Australian and international lessons from prescribing cannabis to implement effective regulation for the medicinal use of MDMA and psilocybin.